David Williams

Newt Gingrich has positioned himself as the “true conservative” in the Republican Presidential primary. And he trumpeted his support for the Medicare Part D drug benefit program, which was spearheaded by Republican majorities in Congress and signed by Republican President George W. Bush.

As states grapple with growing Medicaid costs in an era of sluggish economic growth and antipathy to taxes, they are very pleased when they find a way to increase benefits to citizens while reducing their own expenditures.

Should we just hand uninsured adult diabetics $1000 per year rather than enrolling them in Medicaid?

In Matching Supply to Demand: Addressing the U.S. Primary Care Workforce Shortage, the National Institute for Health Care Reform observes that the primary care workforce expansion components of the Affordable Care Act will not be sufficient to meet demand.

Republican primary voters could help trigger a substantive health care policy debate in this country by giving Jon Huntsman a turn among the frontrunners.

Pfizer received a flurry of attention toward the end of November as its blockbuster statin Lipitor came to the end of its patent protection.

The Bipartisan Options for the Future white paper by Ron Wyden (Senate Democrat from Oregon) and Paul Ryan (Republican Congressman from Wisconsin) is billed as a bold move to reform Medicare.

An important reason that medical costs are so high in Massachusetts is that residents are accustomed to visiting major teaching hospitals for routine care.

Everyone who’s looked at the data knows that the cost of Medicare is killing the federal budget.

I’m pleased to learn that the super committee is seriously contemplating having higher income senior citizens pay more for their Medicare coverage.